Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

For better result, minimum character length is four(4)
Results 181 - 190 of 200 for wx. (0.06 seconds)

BeiGene of Beijing out-licensed the ex-China rights for a...
Shanghai-based PhageLux has received an investment from...
iKang Healthcare Group, the largest private provider of...
WuXi PharmaTech, the largest China-US CRO, has purchased...
Hainan Haiyao of China will take a 49% position in a $41...
China is Asia’s number one biopharma cluster,...
BVCF, a China private equity growth investor specializing...
WuXi PharmaTech, China’s largest CRO/CMO, announced...
Zhejiang Hisun Pharma will collaborate with Ambrx of San...
WuXi PharmaTech and TaiMed Biologics of Taiwan today...
prev | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | next
Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here